Tempus AI
Precision-medicine company combining clinical and molecular data with AI; its oncology assays support tumor profiling, companion diagnostics, therapy matching, and clinical-trial matching.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
NA · Recruiting · Colorectal Cancer
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionNA · Recruiting · Pulmonary Hypertension
Tempus Small Cell Lung Cancer Observational Study (Sculptor)NA · Recruiting · Small Cell Lung Cancer
GEMINI-NSCLC: NSCLC Biomarker StudyNA · Recruiting · Non-Small Cell Lung Cancer
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast MalignanciesNA · Recruiting · Breast Cancer
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic MalignanciesNA · Recruiting · Acute Myeloid Leukaemia (AML)
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/tempus-ai/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.